Because ACKR4 knockdown reduces the tumor infiltrating T-cells and DC mediated tumor-specific T-cell expansion in the TdLNs (Figure 3 and Figure 4), we next evaluated whether ACKR4 knockdown affects the tumor response to immune checkpoint blockade. The gene discussed is ACKR4; the disease is neoplasm.